• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动物和人类模型中的类固醇诱导性萎缩。

Steroid-induced atrophy in an animal and human model.

作者信息

Kirby J D, Munro D D

出版信息

Br J Dermatol. 1976 Mar;94 suppl 12:111-9. doi: 10.1111/j.1365-2133.1976.tb02279.x.

DOI:10.1111/j.1365-2133.1976.tb02279.x
PMID:1268071
Abstract

A ratchet-controlled micrometer screw gauge has been used to measure the changes in skin thickness produced by topical corticosteroids. Measurable thinning of the mouse ear followed repeated daily application of corticosteroids. This response in the animal was used to assess the atrophic potential in a variety of standard formulations. The same compounds were applied to human skin and the changes in thickness measured. Patterns of response and the rank order of thinning obtained from the animal model were found to parallel closely the human results.

摘要

一种棘轮控制的千分尺螺旋测微器已被用于测量局部皮质类固醇引起的皮肤厚度变化。每天重复涂抹皮质类固醇后,小鼠耳朵出现了可测量的变薄现象。动物的这种反应被用来评估各种标准制剂的萎缩潜力。将相同的化合物应用于人体皮肤并测量厚度变化。发现从动物模型获得的反应模式和变薄的等级顺序与人体结果非常相似。

相似文献

1
Steroid-induced atrophy in an animal and human model.动物和人类模型中的类固醇诱导性萎缩。
Br J Dermatol. 1976 Mar;94 suppl 12:111-9. doi: 10.1111/j.1365-2133.1976.tb02279.x.
2
The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
Br J Dermatol. 1976 May;94(5):545-50. doi: 10.1111/j.1365-2133.1976.tb05144.x.
3
Methods for the assessment of skin atrophogenicity of topical corticosteroids.局部用皮质类固醇皮肤萎缩性评估方法。
Dermatologica. 1976;152 Suppl 1:117-26. doi: 10.1159/000257872.
4
Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
Br J Dermatol. 1978 Dec;99(6):655-63. doi: 10.1111/j.1365-2133.1978.tb07060.x.
5
Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Dermatologica. 1976;153(4):236-42. doi: 10.1159/000251062.
6
Different skin thinning potential of equipotent medium-strength glucocorticoids.等效中效糖皮质激素不同的皮肤变薄潜力。
Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):85-91. doi: 10.1159/000049394.
7
Steroid atrophy--a histological appraisal.类固醇性萎缩——组织学评估
Dermatologica. 1976;152 Suppl 1:107-15. doi: 10.1159/000257871.
8
A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.通过比较两种给药方案,研究局部应用类固醇的全身和局部效应。
J Dermatol. 1990 Jan;17(1):28-33. doi: 10.1111/j.1346-8138.1990.tb01605.x.
9
Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
Br J Dermatol. 1978 Dec;99(6):665-73. doi: 10.1111/j.1365-2133.1978.tb07061.x.
10
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.非氟化双酯型局部用糖皮质激素。通过高频超声评估,其在正常皮肤中无萎缩性。
Acta Derm Venereol. 1992;72(3):214-6.

引用本文的文献

1
Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.类固醇恐惧症:有依据吗?局部用皮质类固醇安全性、成瘾和戒断的综述。
Clin Drug Investig. 2021 Oct;41(10):835-842. doi: 10.1007/s40261-021-01072-z. Epub 2021 Aug 18.
2
2940-nm Er:YAG fractional laser enhanced the effect of topical drug for psoriasis.2940纳米铒钇铝石榴石分次激光增强了局部用药治疗银屑病的效果。
Lasers Med Sci. 2017 Aug;32(6):1393-1397. doi: 10.1007/s10103-017-2259-x. Epub 2017 Jun 23.
3
Misuse of topical corticosteroids on the face: A cross-sectional study among dermatology outpatients.
面部外用糖皮质激素的误用:一项皮肤科门诊患者的横断面研究。
Indian Dermatol Online J. 2016 Jul-Aug;7(4):259-63. doi: 10.4103/2229-5178.185492.
4
Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.用于测定糖皮质激素受体配体诱导的皮肤萎缩的测试系统。
Dermatoendocrinol. 2011 Jul;3(3):175-9. doi: 10.4161/derm.3.3.15065. Epub 2011 Jul 1.
5
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.ZK 245186 是一种新型、选择性的糖皮质激素受体激动剂,用于治疗炎症性皮肤病的局部治疗。
Br J Pharmacol. 2009 Oct;158(4):1088-103. doi: 10.1111/j.1476-5381.2009.00238.x. Epub 2009 May 6.
6
Combination of a dual 5-lipoxygenase/cyclooxygenase inhibitor with a glucocorticoid results in synergistic topical antiinflammatory activity without inducing skin atrophy.双重5-脂氧合酶/环氧化酶抑制剂与糖皮质激素联合使用可产生协同的局部抗炎活性,且不会引起皮肤萎缩。
Inflammation. 1993 Oct;17(5):531-6. doi: 10.1007/BF00914191.
7
Glucocorticoid receptors and inhibition of neonatal mouse dermal fibroblast growth in primary culture.糖皮质激素受体与原代培养中新生小鼠真皮成纤维细胞生长的抑制
Arch Dermatol Res. 1980;269(2):111-26. doi: 10.1007/BF00406531.
8
Epidermal thinning: evaluation of commercial corticosteroids.表皮变薄:市售皮质类固醇的评估
Arch Dermatol Res. 1980;267(1):7-24. doi: 10.1007/BF00416917.
9
Topical corticosteroids: clinical pharmacology and therapeutic use.局部用皮质类固醇:临床药理学与治疗应用。
Drugs. 1980 Feb;19(2):119-34. doi: 10.2165/00003495-198019020-00004.
10
Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.使用相同外用皮质类固醇治疗稳定期银屑病的两种治疗方案的比较。
West J Med. 1983 Nov;139(5):657-62.